Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bbbd0c7fb078b0746ba3b4823f6202be5> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bbbd0c7fb078b0746ba3b4823f6202be5 NCIT_P378 "NCI" @default.
- Bbbd0c7fb078b0746ba3b4823f6202be5 type Axiom @default.
- Bbbd0c7fb078b0746ba3b4823f6202be5 annotatedProperty IAO_0000115 @default.
- Bbbd0c7fb078b0746ba3b4823f6202be5 annotatedSource NCIT_C180526 @default.
- Bbbd0c7fb078b0746ba3b4823f6202be5 annotatedTarget "The besylate salt form of clifutinib, an orally bioavailable, selective, small molecule inhibitor of FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2), with potential antineoplastic activity. Upon oral administration, clifutinib targets, binds to and inhibits the activity of FLT3. This inhibits the proliferation of FLT3-expressing cancer cells. FLT3, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias." @default.